-
1Academic Journal
Authors: V. V. Lozovaya, O. A. Malikhova, A. S. Vodoleev, O. A. Gusarova, A. O. Tumanyan, A. G. Malikhov, В. В. Лозовая, О. А. Малихова, А. С. Водолеев, О. А. Гусарова, А. О. Туманян, А. Г. Малихов
Source: Surgery and Oncology; Том 13, № 3 (2023); 11-20 ; Хирургия и онкология; Том 13, № 3 (2023); 11-20 ; 2949-5857
Subject Terms: анальгезия, endosonographic study, pancreatic nET, pancreatic cancer, pancreatic adenocarcinoma, pain syndrome, analgesia, эндосонографическое исследование, нейроэндокринные опухоли поджелудочной железы, рак поджелудочной железы, аденокарцинома поджелудочной железы, болевой синдром
File Description: application/pdf
Relation: https://www.onco-surgery.info/jour/article/view/641/434; Fitzgerald T.L., Hickner Z.J., Schmitz M. et al. Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry. Pancreas 2008;37:134–8. DOI:10.1097/MPA.0b013e318163a329; Jilesen A.P., van Eijck C.H., Busch O.R. et al. Postoperative Outcomes of Enucleation and Standard Resections in Patients with a Pancreatic Neuroendocrine Tumor. World J Surg 2016;40:715–28. DOI:10.1007/s00268-015-3341-9; Mehrabi A., Fischer L., Hafezi M. et al. A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas 2014;43(5):675–86. DOI:10.1097/MPA.0000000000000110; Lee D.W., Kim M.K., Kim H.C. Diagnosis of pancreatic neuroendo crine tumors. Clin Endosc 2017;50:537–45. DOI:10.5946/ce.2017.131; Choi J.H., Seo D.W., Song T.J. et al. Endoscopic ultrasound-guided radiofrequency ablation for management of benign solid pancreatic tumors. Endoscopy 2018;50(11):1099–104. DOI:10.1055/a-0583-8387; Oleinikov K., Dancour A., Epshtein J. et al. Endoscopic ultrasound guided radiofrequency ablation: a new therapeutic approach for pancreatic neuroendocrine tumors. J Clin Endocrinol Metab 2019;104:2637–47. DOI:10.1210/jc.2019-00282; Houmani Z.S., Noureddine M.S. EUS-guided celiac plexus radiofrequency ablation using a novel device. VideoGIE 2020;5(9):395-6. DOI:10.1016/j.vgie.2020.04.022; Lakhtakia S., Seo D.W. Endoscopic ultrasonography-guided tumor ablation. Dig Endosc 2017;29(4):486–94. DOI:10.1111/den.12833; Taewoong medical USA: URL: https://taewoongusa.com/products/viva-combo-rf-generator-system/; Goldberg S.N., Mallery S., Gazelle G.S. et al. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc 1999;50(3):392–401. DOI:10.1053/ge.1999.v50.98847; Carrara S., Arcidiacono P.G., Albarello L. et al. Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas: a preliminary study. Endoscopy 2008;40(4):321–6. DOI:10.1055/s-2007-995595; Kim H.J., Seo D.W., Hassanuddin A. et al. EUS-guided radiofrequency ablation of the porcine pancreas. Gastrointest Endosc 2012;76(5):1039–43. DOI:10.1016/j.gie.2012.07.015; Rossi S., Ravetta V., Rosa L. et al. Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology 2011;53(1):136–47. DOI:10.1002/hep.23965; Rossi S., Dore R., Cascina A. et al. Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Eur Respir J 2006; 27(3):556–63. DOI:10.1183/09031936.06.00052905; Atwell T.D., Schmit G.D., Boorjian S.A. et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol 2013;200(2):461–6. DOI:10.2214/AJR.12.8618; Mohan H., Nicholson P., Winter D.C. et al. Radiofrequency ablation for neuroendocrine liver metastases: a systematic review. J Vasc Interv Radiol 2015;26(7):935–42. DOI:10.1016/j.jvir.2014.12.009; Elias D., Baton O., Sideris L. et al. Necrotizing pancreatitis after radiofrequency destruction of pancreatic tumours. Eur J Surg Oncol 2004;30(1):85–7. DOI:10.1016/j.ejso.2003.10.013; Girelli R., Frigerio I., Salvia R. et al. Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer. Br J Surg 2010;97(2):22–5. DOI:10.1002/bjs.6800; Khoury T., Sbeit W., Napoléon B. Endoscopic ultrasound guided radiofrequency ablation for pancreatic tumors: A critical review focusing on safety, efficacy and controversies. World J Gastroenterol 2023;29(1):157–70. DOI:10.3748/wjg.v29.i1.157; Rossi S., Viera F.T., Ghittoni G. et al. Radiofrequency ablation of pancreatic neuroendocrine tumors: a pilot study of feasibility, efficacy, and safety. Pancreas 2014;43(6):938–45. DOI:10.1097/MPA.0000000000000133; Armellini E., Crino` S.F., Ballare` M. et al. Endoscopic ultrasound-guided radiofrequency ablation of a pancreatic neuroendocrine tumor. Endoscopy 2015;47(S 01):E600–1. DOI:10.1055/s-0034-1393677; Pai M., Habib N., Senturk H. et al. Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors. World J Gastrointest Surg 2015;7(4):52–9. DOI:10.4240/wjgs.v7.i4.52; Lakhtakia S., Ramchandani M., Galasso D. et al. EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos). Gastrointest Endosc 2016;83(1):234–9. DOI:10.1016/j.gie.2015.08.085; Barthet M., Giovannini M., Lesavre N. et al. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study [published online ahead of print 22 January 2019]. Endoscopy 2019;51(9):836–42. DOI:10.1055/a-0824-7067; Bang J.Y., Sutton B., Hawes R.H., Varadarajulu S. EUS-guided celiac ganglion radiofrequency ablation versus celiac plexus neurolysis for palliation of pain in pancreatic cancer: a randomized controlled trial (with videos). Gastrointest Endosc 2019;89(1):58–66. DOI:10.1016/j.gie.2018.08.005
-
2Academic Journal
Authors: V. V. Lozovaya, O. A. Gusarova, O. A. Malikhova, N. S. Besova, A. M. Suleymanova, Yu. V. Sinyagina, A. O. Tumanyan, В. В. Лозовая, О. А. Гусарова, О. А. Малихова, Н. С. Бесова, А. М. Сулейманова, Ю. В. Синягина, А. О. Туманян
Source: Russian Journal of Pediatric Hematology and Oncology; Том 10, № 2 (2023); 99-106 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 10, № 2 (2023); 99-106 ; 2413-5496 ; 2311-1267
Subject Terms: лечение, gastric cancer, pediatric oncology, endoscopic diagnostics, endosonographic examination, radiological diagnostics, treatment, рак желудка, детская онкология, эндоскопическая диагностика, эндосонографическое исследование, рентгенологическая диагностика
File Description: application/pdf
Relation: https://journal.nodgo.org/jour/article/view/941/828; Brecht I.B., Graf N., Schweinitz D.V., Fruhwald M.C., Bielack S.S., Schneider D.T. Networking for children and adolescents with very rare tumors: foundation of the GROH pediatric rare tumor group. Klinische Padiatrie. 2009;221(3):181–5. doi:10.1155/2014/527471.; Zhang W., Liang W.Q., Cai A.Z., Wang P.P., Xi H.Q., Liu G.X., Wei B. Clinicopathological characteristics of gastric cancer in adolescents aged 10–24 years: 17-year experience of 17 years in a single institute. Zhonghua Wei Chang Wai Ke Za Zhi. 2020;23(10):963–8. doi:10.3760/cma.j.cn.441530-20190918-00351.; Al-Hussaini А., AlGhamdi S., Alsaaran R., Al-Kasim F., Habib Z., Ourfali N. Gastric adenocarcinoma presenting with gastric outlet obstruction in a child. Case Rep Gastrointest Med. 2014;2014:527471. doi:10.1155/2014/527471.; Сhang V.Y., Federman N., Martinez-Agosto J., Tatishchev S.F., Nelson S.F. Whole exome sequencing of pediatric gastric adenocarcinoma reveals an atypical presentation of Li-Fraumeni syndrome. Pediatr Blood Cancer. 2013;60:570–4. doi:10.1002/pbc.24316.; Lee Y.T., Ng E.K., Hung L.C., Chung S.C., Ching J.Y., Chan W.Y., Chu W.C., Sung J.J. Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients. Gut. 2005;54:1541–5. doi:10.1136/gut.2004.055772.; Ассоциация онкологов России, Российское общество клинической онкологии. Клинические рекомендации «Рак желудка». M., 2020. 95 c.; Harting M.T., Blakely M.L., Herzog C.E., Lally K.P., Ajani J.A., Andrassy R.J. Treatment issues in pediatric gastric adenocarcinoma. J Pediatr Surg. 2004;39(8):8–10. doi:10.1016/j.jpedsurg.2004.04.043.; Subbiah V., Varadhachary G., Herzog C.E., Huh W.W. Gastric adenocarcinoma in children and adolescents. Pediatr Blood Cancer. 2011;57:524–7. doi:10.1002/pbc.23051.; Kato S., Kikuchi S., Nakajima S. When does gastric atrophy develop in Japanese children? Helicobacter. 2008;13:278–81. doi:10.1111/j.1523-5378.2008.00611.x.; Brenner H., Arndt V., Stürmer T., Stegmaier C., Ziegler H., Dhom G. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer. 2000;88(2):274–9. doi:10.1002/(sici)1097-0142(20000115)88:23.0.co;2-9.; Blaser M.J., Chyou P.H., Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 1995;55(3):562–5. PMID: 7834625.; Mauad E.C., Nogueira J.L., Souza J.M., Wohnrath D.R., Oliveira A.T., Colli G., Colli A.M. Gastric Cancer in Young Adults. Rev Bras Cancerol. 2000;46(3):299–304. doi:10.32635/2176-9745.RBC.2000v46n3.; Sasaki H., Sasano H., Ohi R., Imaizumi M., Shineha R., Nakamura M., Shibuya D., Hayashi Y. Adenocarcinoma at the esophageal gastric junction arising in an 11-year-old girl. Pathol Int. 1999;49(12):1109–13. doi:10.1046/j.1440-1827.1999.00993.x.; Lu J., Huang C.M., Zheng C.H., Li P., Xie J.W., Wang J.B., Lin J.X. Gastric carcinoma in a 12-year-old girl: a case report and literature review. Zhonghua Weichang Waike Zazhi. 2012;15(9):967–70. PMID: 22990936.; Kim D.Y., Ryu S.Y., Kim Y.J., Kim S.K. Clinicopathological characteristics of gastric carcinoma in young patients. Langenbecks Arch Sur. 2003;388(4):245–9. doi:10.1007/s00423-003-0387-1.; Shin S.Y., Park H., Chae S.W., Woo H.Y. Microangiopathic hemolytic anemia as the fi rst manifestation of metastatic signet ring cell carcinoma of unknown origin: a case report and review of literature. Korean J Lab Med. 2011;31(3):157–61. doi:10.3343/kjlm.2011.31.3.157.; Chu P.G., Weiss L.M. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol. 2004;121(6):884–92. doi:10.1309/A09E-RYMF-R64N-ERDW.; Nagtegaal I.D., Odze R.D., Klimstra D., Paradis V., Rugge M., Schirmacher P., Washington K.M., Carneiro F., Cree I.A. The 2019 WHO classifi cation of tumours of the digestive system. Histopathology. 2020;76(2):182–8. doi:10.1111/his.13975.; Pernot S., Voron T., Perkins G., Lagorce-Pages C., Berger A., Taieb J. Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015;21(40):11428–38. doi:10.3748/wjg.v21.i40.11428.; Давыдов М.И., Тер-Ованесов М.Д., Абдихакимов А.Н. Рак желудка: предоперационное обследование и актуальные вопросы стадирования. Практическая онкология. 2003;3:9–17.; Curtis J.L., Burns R.C., Wang L., Mahour G.H., Ford H.R. Primary gastric tumors of infancy and childhood: 54-year experience at a single institution. J Pediatr Surg. 2008;43(8):1487–93. doi:10.1016/j.jpedsurg.2007.11.016.; Tessler R.A., Dellinger M., Richards M.K., Goldin A.B., Beierle E.A., Doski J.J., Goldfarb M., Langer M., Nuchtern J.G., Raval M.V., Vasudevan S., Gow K.W. Pediatric gastric adenocarcinoma: A National Cancer Data Base review. J Pediatr Surg. 2019;54(5):1029–34. doi:10.1016/j.jpedsurg.2019.01.048.; Slotta J.E., Heine S., Kauff els A., Krenn T., Grünhage F., Wagner M., Graf N., Schilling M.K., Schuld J. Gastrectomy with isoperistaltic jejunal parallel pouch in a 15-year-old adolescent boy with gastric adenocarcinoma and autosomal recessive agammaglobulinemia. J Pediatr Surg. 2011;46:e21–4. doi:10.1016/j.jpedsurg.2011.06.005.; Varadhachary G., Ajani J.A. Preoperative and adjuvant therapies for upper gastrointestinal cancers. Expert Rev Anticancer Ther. 2005;5:719–25. doi:10.1586/14737140.5.4.719.; Bartley A.N., Washington M.K., Colasacco C., Ventura C.B., Ismaila N., Benson A.B. 3rd, Carrato A., Gulley M.L., Jain D., Kakar S., Mackay H., Streutker C., Tang L., Troxell M., Ajani J.A. HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society of Clinical Pathology, and American Society of Clinical Oncology. J Clin Oncol. 2017;35(4):446–64. doi:10.1200/JCO.2016.69.4836.; Bartley A.N., Fitzgibbons P.L., Broaddus R.R., Shi C. Template for Reporting Results of DNA Mismatch Repair Testing in Patients Being Considered for Checkpoint Inhibitor Immunotherapy. College of American Pathologists 2018;1–2.; Le D.T., Uram J.N., Wang H., Bartlett B.R., Kemberling H., Eyring A.D., Skora A.D., Luber B.S., Azad N.S., Laheru D., Biedrzycki B., Donehower R.C., Zaheer A., Fisher G.A., Crocenzi T.S., Lee J.J., Duff y S.M., Goldberg R.M., de la Chapelle A., Koshiji M., Bhaijee F., Huebner T., Hruban R.H., Wood L.D., Cuka N., Pardoll D.M., Papadopoulos N., Kinzler K.W., Zhou S., Cornish T.C., Taube J.M., Anders R.A., Eshleman J.R., Vogelstein B., Diaz L.A. Jr. PD-1 Blockade in Tumors with Mismatch-Repair Defi ciency. N Engl J Med. 2015;372(26):2509–20. doi:10.1056/NEJMoa1500596.; Joshi S.S., Badgwell B.D. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264–79. doi:10.3322/caac.21657.; Blair V.R., McLeod M., Carneiro F., Coit D.G., D’Addario J.L., van Dieren J.M., Harris K.L., Hoogerbrugge N., Oliveira C., van der Post R.S., Arnold J., Benusiglio P.R., Bisseling T.M., Boussioutas A., Cats A., Charlton A., Schreiber K.E.C., Davis J.L., Pietro M.D., Fitzgerald R.C., Ford J.M., Gamet K., Gullo I., Hardwick R.H., Huntsman D.G., Kaurah P., Kupfer S.S., Latchford A., Mansfi eld P.F., Nakajima T., Parry S., Rossaak J., Sugimura H., Svrcek M., Tischkowitz M., Ushijima T., Yamada H., Yang H.K., Claydon A., Figueiredo J., Paringatai K., Seruca R., Bougen-Zhukov N., Brew T., Busija S., Carneiro P., DeGregorio L., Fisher H., Gardner E., Godwin T.D., Holm K.N., Humar B., Lintott C.J., Monroe E.C., Muller M.D., Norero E., Nouri Y., Paredes J., Sanches J.M., Schulpen E., Ribeiro A.S., Sporle A., Whitworth J., Zhang L., Reeve A.E., Guilford P. Hereditary diff use gastric cancer: updated clinical practice guidelines. Lancet Oncol. 2020;21(8):e386–97. doi:10.1016/S1470-2045(20)30219-9.; Namikawa K., Kawachi H., Tsugeno Y., Nakajima T., Fujisaki J. Detection of multiple intramucosal signet-ring cell carcinomas by white-light endoscopy and magnifying endoscopy with narrow-band imaging in a hereditary diff use gastric cancer patient with a CDH1 germline mutation. VideoGIE. 2021;13;6(4):163–6. doi:10.1016/j.vgie.2020.11.020.; Fujiyoshi M.R.A., Inoue H., Fujiyoshi Y., Nishikawa Y., Toshimori A., Shimamura Y., Tanabe M., Ikeda H., Onimaru M. Endoscopic Classifi cations of Early Gastric Cancer: A Literature Review. Cancers. 2022;14(1):100. doi:10.3390/cancers14010100.; Phalanusitthepha C., Grimes K.L., Ikeda H., Sato H., Sato C., Hokierti C., Inoue H. Endoscopic features of early-stage signet-ringcell carcinoma of the stomach. World J Gastrointest Endosc. 2015;7(7):741–6. doi:10.4253/wjge.v7.i7.741.; Zhou H., Li M. The Value of Gastric Cancer Staging by Endoscopic Ultrasonography Features in the Diagnosis of Gastroenterology. Comput Math Methods Med. 2022;18(2022):6192190. doi:10.1155/2022/6192190.; Morgant S., Artru P., Oudjit A., Lourenco N., Pasquer A., Walter T., Gornet J.M., Rouquette A., Brezault C., Coriat R. Endoscopic ultrasound efficacy in staging gastric linitisplastica lesion: a retrospective multicentric French study. Ann Transl Med. 2021;9(1):50. doi:10.21037/atm-20-3474.; https://journal.nodgo.org/jour/article/view/941